Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Cardiovascular4053 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A26843 | 19670076 | Scand J Gastroenterol | Final results of a long-term, clinical follow-up in fatty liver patients. | 2009 | Details |
A26851 | 19652102 | Arch Pediatr Adolesc Med | Onset of puberty and cardiovascular risk factors in untreated obese children and adolescents: a 1-year follow-up study. | 2009 | Details |
A26858 | 19637286 | Hepatology | Advances in pediatric nonalcoholic fatty liver disease. | 2009 | Details |
A26862 | 19627660 | Curr Treat Options Cardiovasc Med | Use of statins in patients with liver disease. | 2009 | Details |
A26867 | 19622617 | J Clin Endocrinol Metab | Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic resonance spectroscopy. | 2009 | Details |
A26876 | 19601771 | Curr HIV Res | The changing face of HIV/AIDS in treated patients. | 2009 | Details |
A26884 | 19588647 | J Assoc Physicians India | Non-alcoholic fatty liver disease (NAFLD)--the hepatic component of metabolic syndrome. | 2009 | Details |
A26888 | 19584186 | J Clin Endocrinol Metab | Nonalcoholic fatty liver is not associated with carotid intima-media thickness in type 2 diabetic patients. | 2009 | Details |
A26904 | 19560226 | J Hepatol | Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. | 2009 | Details |
A26914 | 19381123 | Ann Hepatol | Nonalcoholic fatty liver disease and its association with cardiovascular disease. | 2009 | Details |
A26955 | 19466213 | Arq Bras Endocrinol Metabol | Protective roles of adiponectin in obesity-related fatty liver diseases: mechanisms and therapeutic implications. | 2009 | Details |
A26971 | 19442917 | Clin Liver Dis | Nonalcoholic fatty liver disease: a practical approach to evaluation and management. | 2009 | Details |
A26972 | 19440836 | Dig Dis Sci | Levels of soluble CD40 ligand and P-Selectin in nonalcoholic fatty liver disease. | 2009 | Details |
A26982 | 19413701 | Obes Rev | Non-alcoholic fatty liver disease is associated with cardiovascular disease risk markers. | 2009 | Details |
A27060 | 19243311 | Clin Sci (Lond) | Metabolic disturbances in non-alcoholic fatty liver disease. | 2009 | Details |
A27065 | 19230890 | Atherosclerosis | Losartan reduces liver expression of plasminogen activator inhibitor-1 (PAI-1) in a high fat-induced rat nonalcoholic fatty liver disease model. | 2009 | Details |
A27066 | 19187068 | Liver Int | Metabolic syndrome, non-alcoholic fatty liver disease and hepatitis C virus: impact on disease progression and treatment response. | 2009 | Details |
A27082 | 19215335 | J Gastroenterol Hepatol | An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome. | 2009 | Details |
A27087 | 19199918 | Curr Med Chem | Obesity: pathophysiology and clinical management. | 2009 | Details |
A27104 | 19166967 | Biochim Biophys Acta | Stearoyl-CoA desaturase and its relation to high-carbohydrate diets and obesity. | 2009 | Details |
A27105 | 19166659 | Curr Gastroenterol Rep | Nonalcoholic fatty liver disease and cardiovascular risk. | 2009 | Details |
A27109 | 19159884 | Atherosclerosis | Elevated alanine aminotransferase levels predict mortality from cardiovascular disease and diabetes in Koreans. | 2008 | Details |
A27151 | 19075784 | Endocr Metab Immune Disord Drug Targets | Does non-alcoholic fatty liver disease (NAFLD) increase cardiovascular risk? | 2008 | Details |
A27152 | 19074370 | J Lipid Res | Nonalcoholic fatty liver disease. | 2008 | Details |
A27162 | 19067776 | J Gastroenterol Hepatol | Effect of a lifestyle intervention in patients with abnormal liver enzymes and metabolic risk factors. | 2008 | Details |
A27163 | 19065650 | Hepatology | Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management. | 2009 | Details |
A27186 | 19016656 | Clin Sci (Lond) | Is liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis. | 2008 | Details |
A27187 | 19016382 | Scand J Gastroenterol | Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease. | 2009 | Details |
A27190 | 19014878 | J Hepatol | Epidemiology of non-alcoholic fatty liver disease in China. | 2008 | Details |
A27194 | 19010326 | Gastroenterology | Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease. | 2008 | Details |
A27215 | 18957882 | Curr Opin Lipidol | The trials and tribulations of the treatment of nonalcoholic fatty-liver disease. | 2008 | Details |
A27220 | 18956294 | Semin Liver Dis | Hepatic, cardiovascular, and endocrine outcomes of the histological subphenotypes of nonalcoholic fatty liver disease. | 2008 | Details |
A27242 | 18854760 | J Hypertens | Nonalcoholic fatty liver disease, adiponectin and insulin resistance in dipper and nondipper essential hypertensive patients. | 2008 | Details |
A27244 | 18853984 | Am J Gastroenterol | Association between non-alcoholic fatty liver disease and cardiovascular disease: a first message should pass. | 2008 | Details |
A27248 | 18839055 | Acta Diabetol | Insulin resistance and exercise capacity in male children and adolescents with non-alcholic fatty liver disease. | 2008 | Details |
A27262 | 18813860 | Int J Mol Med | Therapeutic effect of ARBs on insulin resistance and liver injury in patients with NAFLD and chronic hepatitis C: a pilot study. | 2008 | Details |
A27275 | 18774133 | Atherosclerosis | The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects. | 2008 | Details |
A27280 | 18762907 | Diabetologia | Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon? | 2008 | Details |
A27281 | 18760271 | Clin Chim Acta | A preliminary investigation of the association between haptoglobin polymorphism, serum ferritin concentration and fatty liver disease. | 2008 | Details |
A27303 | 18684196 | Am J Gastroenterol | Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. | 2008 | Details |
A27308 | 18682312 | J Hepatol | Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. | 2008 | Details |
A27339 | 18617457 | Orv Hetil | [Non-alcoholic fatty liver disease and cardiovascular risk]. | 2008 | Details |
A27350 | 18594178 | Korean J Lab Med | [Metabolic characteristics and associated factors of nonalcoholic fatty liver disease diagnosed at medical checkups]. | 2008 | Details |
A27351 | 18591439 | Circulation | Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease. | 2008 | Details |
A27358 | 18564173 | Diabetes Obes Metab | Current treatment of non-alcoholic fatty liver disease. | 2008 | Details |
A27362 | 18554746 | J Hepatol | Liver and heart: a new link? | 2008 | Details |
A27367 | 18532884 | Clin Infect Dis | Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors. | 2008 | Details |
A27382 | 18505888 | J Clin Pathol | Clinical and laboratory diagnosis of the metabolic syndrome. | 2008 | Details |
A27404 | 18426499 | J Neuroendocrinol | The endocannabinoid system and liver diseases. | 2008 | Details |
A27412 | 18442193 | World J Gastroenterol | Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment. | 2008 | Details |
A27417 | 18422468 | Expert Opin Pharmacother | Pleiotropic effects of thiazolidinediones. | 2008 | Details |
A27419 | 18420211 | Atherosclerosis | Do we need to consider inflammatory markers when we treat atherosclerotic disease? | 2008 | Details |
A27420 | 18419637 | J Dig Dis | Impact of non-alcoholic fatty liver disease on accelerated metabolic complications. | 2008 | Details |
A27422 | 18417046 | Curr Gastroenterol Rep | Nonalcoholic fatty liver disease as a component of the metabolic syndrome. | 2008 | Details |
A27431 | 18396752 | Acta Gastroenterol Belg | The metabolic syndrome and the liver. | 2008 | Details |
A27452 | 18367860 | Korean J Hepatol | [Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis]. | 2008 | Details |
A27454 | 18362435 | Circ J | Evaluation of vulnerable coronary plaques and non-alcoholic fatty liver disease (NAFLD) by 64-detector multislice computed tomography (MSCT). | 2008 | Details |
A27456 | 18356751 | Pediatr Res | Nonalcoholic fatty liver disease and carotid atherosclerosis in children. | 2008 | Details |
A27469 | 18330098 | Acta Gastroenterol Belg | Statins in hepatobiliary diseases: effects, indications and risks. | 2008 | Details |
A27480 | 18311774 | Hepatology | Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: Possible pathogenetic role in NASH. | 2008 | Details |
A27482 | 19885351 | J Diabetes Sci Technol | Effects of exenatide on diabetes, obesity, cardiovascular risk factors, and hepatic biomarkers in patients with type 2 diabetes. | 2008 | Details |
A27484 | 18304679 | J Hepatol | Non-alcoholic fatty liver disease: the mist gradually clears. | 2008 | Details |
A27487 | 18299664 | Minerva Gastroenterol Dietol | The clinical aspects of non-alcoholic fatty liver disease. | 2008 | Details |
A27508 | 18240340 | World J Gastroenterol | The blind men 'see' the elephant-the many faces of fatty liver disease. | 2008 | Details |
A27515 | 18218674 | Gut | Waist circumference correlates with liver fibrosis in children with non-alcoholic steatohepatitis. | 2008 | Details |
A27544 | 18094066 | Am J Physiol Regul Integr Comp Physiol | Skeletal muscle insulin resistance: role of inflammatory cytokines and reactive oxygen species. | 2007 | Details |
A27548 | 18086620 | Hepatobiliary Pancreat Dis Int | Metabolic syndrome and non-alcoholic fatty liver disease: Asian definitions and Asian studies. | 2007 | Details |
A27563 | 18058083 | Diabetologia | Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients. | 2007 | Details |
A27565 | 18056890 | Diabetes Care | Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects. | 2007 | Details |
A27572 | 18031368 | J Gastroenterol Hepatol | Significant correlations between severe fatty liver and risk factors for metabolic syndrome. | 2007 | Details |
A27577 | 17935056 | Diab Vasc Dis Res | The role of fenofibrate in clinical practice. | 2007 | Details |
A27599 | 17939039 | Dig Dis Sci | Evaluation of metabolic syndrome frequency and carotid artery intima-media thickness as risk factors for atherosclerosis in patients with nonalcoholic fatty liver disease. | 2007 | Details |
A27619 | 17902213 | Int J Pediatr Obes | Estimated burden of paediatric obesity and co-morbidities in Europe. Part 2. Numbers of children with indicators of obesity-related disease. | 2006 | Details |
A27623 | 17896181 | Eur J Epidemiol | Prevalence of non-alcoholic fatty liver and characteristics in overweight adolescents in the general population. | 2007 | Details |
A27654 | 17725609 | Intern Med J | Endothelial dysfunction in Turkish patients with non-alcoholic fatty liver disease. | 2007 | Details |
A27677 | 17690317 | Arterioscler Thromb Vasc Biol | Fatty liver: a novel component of the metabolic syndrome. | 2007 | Details |
A27683 | 17675901 | J Cardiometab Syndr | Nonalcoholic steatohepatitis and the cardiometabolic syndrome. | 2006 | Details |
A27712 | 17593595 | Medicina (B Aires) | Alanine-aminotransferase: an early marker for insulin resistance? | 2007 | Details |
A27716 | 17565632 | J Gastroenterol Hepatol | How should we manage patients with non-alcoholic fatty liver disease in 2007? | 2007 | Details |
A27724 | 17560098 | Nutr Metab Cardiovasc Dis | Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question. | 2007 | Details |
A27729 | 17547835 | Curr Diab Rep | Nonalcoholic fatty liver disease and cardiovascular disease risk. | 2007 | Details |
A27734 | 17544974 | Clin Liver Dis | Metabolic syndrome and NASH. | 2007 | Details |
A27761 | 17498218 | J Gastroenterol Hepatol | What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific? | 2007 | Details |
A27762 | 17496361 | Indian J Med Res | Antioxidants: do they have a role in the treatment of insulin resistance? | 2007 | Details |
A27781 | 17464986 | Hepatology | Polymorphism in microsomal triglyceride transfer protein: a link between liver disease and atherogenic postprandial lipid profile in NASH? | 2007 | Details |
A27783 | 17461452 | World J Gastroenterol | Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. | 2007 | Details |
A27784 | 17458697 | Dig Dis Sci | Association among C-reactive protein, Fatty liver disease, and cardiovascular risk. | 2007 | Details |
A27790 | 17439070 | Recenti Prog Med | [Obesity in adolescents: physical correlated pathologies, and therapeutic state of art]. | 2007 | Details |
A27797 | 17405346 | Eur Rev Med Pharmacol Sci | Influence of insulin resistance in obese patients on elevated serum alanine aminotransferase. | 2007 | Details |
A27807 | 17392599 | J Endocrinol Invest | Ultrasonographic evaluation of liver volume and the metabolic syndrome in obese women. | 2007 | Details |
A27809 | 17391316 | Am J Gastroenterol | Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study. | 2007 | Details |
A27824 | 17353063 | Diabetes Res Clin Pract | The association of serum gamma glutamyltransferase with components of the metabolic syndrome in the Korean adults. | 2007 | Details |
A27844 | 17277038 | Diabetes Care | Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. | 2007 | Details |
A27861 | 17227317 | Diabet Med | Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens. | 2007 | Details |
A27922 | 17007049 | World J Gastroenterol | Fatty liver, carotid disease and gallstones: a study of age-related associations. | 2006 | Details |
A27925 | 17006923 | Hepatology | Long-term follow-up of patients with NAFLD and elevated liver enzymes. | 2006 | Details |
A27929 | 16970951 | Atherosclerosis | Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. | 2006 | Details |
A27935 | 16953843 | Liver Int | Incretin mimetics as a novel therapeutic option for hepatic steatosis. | 2006 | Details |
A27938 | 16942668 | Curr Treat Options Gastroenterol | Nonalcoholic Fatty Liver Disease (NAFLD): Approach in the Adolescent Patient. | 2006 | Details |
A27946 | 16931493 | Obesity (Silver Spring) | Relationship of metabolic risk factors and development of cardiovascular disease and diabetes. | 2006 | Details |